Bolt Biotherapeutics, Inc. (BOLT)
4.95
-0.10
(-1.98%)
USD |
NASDAQ |
Feb 23, 15:51
Bolt Biotherapeutics Profit Margin (Quarterly) : -329.4% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -86.41% |
| Return on Assets | -49.02% |
| Return on Invested Capital | -58.81% |
| Gross Profit Margin (Quarterly) | 86.63% |
| Operating Margin (Quarterly) | -355.1% |
| Return on Net Operating Assets | -188.7% |